Skip to main content
OpenTrials

Clinical trial condition

Gout Flare

Explore clinical trials studying Gout Flare. Study availability and eligibility vary by location and protocol.

15 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Gout Flare trial results

Recruiting

Home Hospital for Suddenly Ill Adults

NCT03524222

Conditions
Anticoagulants; Increased, Asthma, Atrial Fibrillation Rapid, +33 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Brigham and Women's Faulkner Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

NCT05658575

Conditions
Acute Gout Flare, Arthralgia, Arthritis, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Arthritis & Rheumatology Associates - Glendale Glendale, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates (AARA), P.C. - Mesa Mesa, Arizona, United States
  • American Institute of Research Los Angeles, California, United States
View all 40 locations
View Trial Details
Recruiting

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

NCT07145229

Conditions
Acute Gout Flare, Acute Gouty Arthritis, Arthritis, +13 more
Locations
  • Onyx Clinical Research Peoria, Arizona, United States
  • Exinia Research La Mesa, California, United States
  • Evergreen Clinical Trial Norcross, Georgia, United States
  • Bioluminux Clinical Research Naperville, Illinois, United States
View all 38 locations
View Trial Details
Not Yet Recruiting

24-Week Recurrence Rate of Gout Following Firsekibart Treatment

NCT07625514

Conditions
Gout Flare
Locations
  • Fuzhou University Affiliated Provincial Hospital Fuzhou, China
  • The Second Affiliated Hospital of Zhejiang Chinese Medical University Hangzhou, China
  • The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, China
  • Tongde Hospital of Zhejiang Province Hangzhou, China
View Trial Details
Completed

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

NCT05586958

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Medvin Clinical Research Covina, California, United States
  • Clinical Research of West Florida, Inc. Clearwater, Florida, United States
  • Herco Medical and Research Center, Inc Coral Gables, Florida, United States
View all 52 locations
View Trial Details

Related conditions